October 6: The Week in Cancer News
Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.
Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.
Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.
Approvals issued in July, August, and September 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new bispecific T-cell engagers for multiple myeloma, a special kit to treat liver metastases from uveal melanoma, and more.
Study links proper dental hygiene to increased survival in head and neck cancer, and researchers use breast milk to detect breast cancer in new mothers.
New report charts progress in cancer care, and immediate access to test results can lead to confusion.
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and more news selected by the editors of Cancer Today.
Study finds association between lorazepam use and poorer cancer outcomes, and weight-loss surgery linked to lower cancer risk in women.
Study suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.